Physician profile
Fernando Dominguez
NPI 1972917672
$5,777.42
in general payments reported to CMS, 2019-2025
7 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2021: $194 · 2022: $25.88 · 2023: $107 · 2024: $4,778 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,670 · Travel and Lodging: $1,417 · Food and Beverage: $1,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,670.00 |
| Travel and Lodging | $1,417.16 |
| Food and Beverage | $1,316.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $5,008.25 | 2021-2025 | Epclusa, Biktarvy |
| Viiv Healthcare Company | $385.96 | 2021-2024 | Dovato |
| Madrigal Pharmaceuticals | $171.68 | 2024-2025 | Rezdiffra, Resmetirom |
| Janssen Pharmaceuticals, INC | $141.87 | 2019 | |
| Abbvie INC. | $32.21 | 2024 | |
| Insmed, INC. | $24.92 | 2025 | Arikayce |
| Allergan, INC. | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Dominguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.